@article{8751259,
  abstract     = {{N-Piperidinyl etonitazene ('etonitazepipne') represents a recent addition to the rapidly expanding class of 2-benzylbenzimidazole `nitazene' opioids. Following its first identification in an online-sourced powder and in biological samples from a patient seeking help for detoxification, this report details its in-depth chemical analysis and pharmacological characterization. Analysis of the powder via different techniques (LC-HRMS, GC-MS, UHPLC-DAD, FT-IR) led to the unequivocal identification of N-piperidinyl etonitazene. Furthermore, we report the first activity-based detection and analytical identification of N-piperidinyl etonitazene in authentic samples. LC-HRMS analysis revealed concentrations of 1.21 ng/mL in serum and 0.51 ng/mL in urine, whereas molecular networking enabled the tentative identification of various (potentially active) urinary metabolites. In addition, we determined that the extent of opioid activity present in the patient's serum was equivalent to the in vitro opioid activity exerted by 2.5-10 ng/mL fentanyl or 10-25 ng/mL hydromorphone in serum. Radioligand binding assays in rat brain tissue revealed that the drug binds with high affinity (K-i= 14.3 nM) to the mu-opioid receptor (MOR). Using a MOR-beta-arrestin2 activation assay, we found that N-piperidinyl etonitazene is highly potent (EC50 = 2.49 nM) and efficacious (E-max = 183% versus hydromorphone) in vitro. Pharmacodynamic evaluation in male Sprague Dawley rats showed that N-piperidinyl etonitazene induces opioid-like antinociceptive, cataleptic, and thermic effects, its potency in the hot plate assay (ED50 = 0.0205 mg/kg) being comparable to that of fentanyl (ED50 = 0.0209 mg/kg), and > 190 times higher than that of morphine (ED50 = 3.940 mg/kg). Taken together, our findings indicate that N-piperidinyl etonitazene is a potent opioid with the potential to cause harm in users.}},
  author       = {{Vandeputte, Marthe and Verougstraete, Nick and Walther, Donna and Glatfelter, Grant C. and Malfliet, Jeroen and Baumann, Michael H. and Verstraete, Alain and Stove, Christophe}},
  issn         = {{0340-5761}},
  journal      = {{ARCHIVES OF TOXICOLOGY}},
  keywords     = {{New synthetic opioids (NSOs),2-benzylbenzimidazole 'nitazene' opioids,Activity-based detection,N-piperidinyl etonitazene 'etonitazepipne',New psychoactive substances (NPS),mu-opioid receptor,UND VERWANDTE HETEROCYCLEN,MORPHINE,SYSTEM}},
  language     = {{eng}},
  number       = {{6}},
  pages        = {{1865--1880}},
  title        = {{First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass}},
  url          = {{http://doi.org/10.1007/s00204-022-03294-2}},
  volume       = {{96}},
  year         = {{2022}},
}

Altmetric

View in Altmetric

Web of Science

Times cited: